1. Home
  2. TSLX vs RCKT Comparison

TSLX vs RCKT Comparison

Compare TSLX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$17.39

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.13

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
RCKT
Founded
2010
1999
Country
United States
United States
Employees
N/A
202
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
401.6M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
TSLX
RCKT
Price
$17.39
$3.13
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$21.61
$29.73
AVG Volume (30 Days)
709.7K
2.0M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
10.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.20
$64.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.99
$2.19
52 Week High
$25.17
$6.43

Technical Indicators

Market Signals
Indicator
TSLX
RCKT
Relative Strength Index (RSI) 38.94 39.28
Support Level $17.26 $3.02
Resistance Level $18.65 $3.52
Average True Range (ATR) 0.51 0.24
MACD -0.11 -0.05
Stochastic Oscillator 4.60 25.69

Price Performance

Historical Comparison
TSLX
RCKT

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: